RTX Corporation removed from BofA Global Research’s US 1 list
RTX•BofA Global Research removed RTX Corporation from its US 1 list.
Related News
Verastem target price raised to $22 from $18 by Alliance Global Partners
VSTM•
US September retail sales data
SPY•
UK government says it is minded to intervene in Sky-ITV deal
CMCSA•
OPKO jumps on sale of select assets to Labcorp for up to $872 million
LH•
CytoDyn to host investor webcast on corporate and clinical progress
CYDY•